# Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation

> **NCT01674530** · PHASE3 · COMPLETED · sponsor: **Dr. Reddy's Laboratories Limited** · enrollment: 909 (actual)

## Conditions studied

- Chronic Idiopathic Constipation

## Interventions

- **DRUG:** Lubiprostone
- **DRUG:** Lubiprostone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01674530
- **Lead sponsor:** Dr. Reddy's Laboratories Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-03
- **Target enrollment:** 909 (ACTUAL)
- **Last updated:** 2014-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01674530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01674530, "Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation". Retrieved via AI Analytics 2026-06-19 from https://api.ai-analytics.org/clinical/NCT01674530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*